Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

SL Topalian, JM Taube, RA Anders… - Nature Reviews Cancer, 2016 - nature.com
With recent approvals for multiple therapeutic antibodies that block cytotoxic T lymphocyte
associated antigen 4 (CTLA4) and programmed cell death protein 1 (PD1) in melanoma …

5-fluorouracil: mechanisms of action and clinical strategies

DB Longley, DP Harkin, PG Johnston - Nature reviews cancer, 2003 - nature.com
Fluorouracil (5-FU) is widely used in the treatment of cancer. Over the past 20 years,
increased understanding of the mechanism of action of 5-FU has led to the development of …

Lessons from hereditary colorectal cancer

KW Kinzler, B Vogelstein - Cell, 1996 - cell.com
A large body of evidence supports the idea that accumution of mutant APC alleles in affected
kindreds (Groden lated genetic changes underlie the development of neoet al., 1991; …

Somatic genomic testing in patients with metastatic or advanced cancer: ASCO provisional clinical opinion

D Chakravarty, A Johnson, J Sklar… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE An ASCO provisional clinical opinion offers timely clinical direction to ASCO's
membership following publication or presentation of potentially practice-changing data from …

Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma

JG Herman, A Umar, K Polyak… - Proceedings of the …, 1998 - National Acad Sciences
Inactivation of the genes involved in DNA mismatch repair is associated with microsatellite
instability (MSI) in colorectal cancer. We report that hypermethylation of the 5′ CpG island …

BCL-2 family: regulators of cell death

DT Chao, SJ Korsmeyer - Annual review of immunology, 1998 - annualreviews.org
▪ Abstract An expanding family of BCL-2 related proteins share homology, clustered within
four conserved regions, namely BCL-2 homology (BH1-4) domains, which control the ability …

DNA mismatch repair in cancer

M Baretti, DT Le - Pharmacology & therapeutics, 2018 - Elsevier
Microsatellite instability (MSI) refers to the hypermutator phenotype secondary to frequent
polymorphism in short repetitive DNA sequences and single nucleotide substitution, as …

Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer

R Gryfe, H Kim, ETK Hsieh, MD Aronson… - … England Journal of …, 2000 - Mass Medical Soc
Background Colorectal cancer can arise through two distinct mutational pathways:
microsatellite instability or chromosomal instability. We tested the hypothesis that colorectal …

A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines

MA Rodriguez-Bigas, CR Boland… - Journal of the …, 1997 - academic.oup.com
Hereditary nonpolyposis colorectal cancer (HNPCC) is a distinct autosomal dominant
syndrome accounting for approximately 5%–6% of the total colorectal cancer burden with …

Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease

LA Aaltonen, R Salovaara, P Kristo… - … England Journal of …, 1998 - Mass Medical Soc
Background Genetic disorders that predispose people to colorectal cancer include the
polyposis syndromes and hereditary nonpolyposis colorectal cancer. In contrast to the …